483
Emergent BioSolutions Canada Inc.FDA 483 - Emergent BioSolutions Canada Inc. - May 12, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Emergent BioSolutions Canada Inc. in Winnipeg revealed significant deficiencies in quality control, data integrity, and manufacturing processes. Observations included failures in sample handling, investigation of product discrepancies, change control, equipment qualification and maintenance, and employee training. These issues indicate a systemic lack of adherence to established procedures and controls for biologics drug manufacturing.
Open in Dashboard
ID · a5330eb6-cd14-45e1-b45f-c51436ec1117